Covered recipient · General Payments record

ALYSSA ASHLEY CHURCHILL

Allopathic & Osteopathic Physicians Internal Medicine

NPI: 1699018135
CMS profile: 1381151
Location: GRAND RAPIDS, MI

General Payments · PY2020–2024

$1,568.05

Reported across 76 records
CMS publication 2026-01-23

Latest program year · PY2024

$1,158.41

55 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated

The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of payment	Amount	Records
Food and Beverage	$1,158.41	55

By paying entity

PY2024 · sorted by reported total

Paying entity	Amount	Records
Novo Nordisk AS	$257.55	14
Acerta Pharma LLC	$190.64	6
Boehringer Ingelheim Pharmaceuticals, Inc.	$108.29	5
PFIZER INC.	$87.57	4
Sumitomo Pharma America, Inc.	$69.79	3
IDORSIA PHARMACEUTICALS US INC	$55.20	3
Lilly USA, LLC	$52.75	3
Antares Pharma, Inc.	$51.23	3
GlaxoSmithKline, LLC.	$45.65	3
E.R. Squibb & Sons, L.L.C.	$40.31	2
Bayer HealthCare Pharmaceuticals Inc.	$37.44	2
Astellas Pharma US Inc	$32.79	1
Exact Sciences Corporation	$29.90	1
ABBVIE INC.	$29.60	1
Amgen Inc.	$21.16	1
NOVARTIS PHARMACEUTICALS CORPORATION	$19.83	1
Esperion Therapeutics, Inc.	$14.84	1
Kowa Pharmaceuticals America, Inc.	$13.87	1

By program year

All program years on this page · sorted by year

Program year	Amount	Records
PY2020	$19.33	1
PY2022	$14.07	1
PY2023	$376.24	19
PY2024	$1,158.41	55

Payment records · PY2024 (55)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2020 2022 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.

Paying entity	Amount	Date	Nature of payment	Dispute status	Published	Record ID	Source
ABBVIE INC.	$29.60	04/17/2024	Food and Beverage	Undisputed	01/23/2026	1103473533	CMS
Amgen Inc.	$21.16	06/20/2024	Food and Beverage	Undisputed	01/23/2026	1117224576	CMS
Antares Pharma, Inc.	$15.11	03/05/2024	Food and Beverage	Undisputed	01/23/2026	1146453401	CMS
Antares Pharma, Inc.	$19.49	06/05/2024	Food and Beverage	Undisputed	01/23/2026	1146453405	CMS
Antares Pharma, Inc.	$16.63	10/28/2024	Food and Beverage	Undisputed	01/23/2026	1146453410	CMS
Astellas Pharma US Inc	$32.79	07/09/2024	Food and Beverage	Undisputed	01/23/2026	1139285684	CMS
AstraZeneca Pharmaceuticals LP	$17.29	03/25/2024	Food and Beverage	Undisputed	01/23/2026	1104601572	CMS
AstraZeneca Pharmaceuticals LP	$19.05	08/06/2024	Food and Beverage	Undisputed	01/23/2026	1105564880	CMS
AstraZeneca Pharmaceuticals LP	$124.99	09/19/2024	Food and Beverage	Undisputed	01/23/2026	1105287385	CMS
AstraZeneca Pharmaceuticals LP	$14.61	10/31/2024	Food and Beverage	Undisputed	01/23/2026	1104441629	CMS
AstraZeneca Pharmaceuticals LP	$1.28	10/31/2024	Food and Beverage	Undisputed	01/23/2026	1104639053	CMS
AstraZeneca Pharmaceuticals LP	$13.42	12/15/2024	Food and Beverage	Undisputed	01/23/2026	1104567556	CMS
Bayer Healthcare Pharmaceuticals Inc.	$18.73	08/08/2024	Food and Beverage	Undisputed	01/23/2026	1086204221	CMS
Bayer Healthcare Pharmaceuticals Inc.	$18.71	10/15/2024	Food and Beverage	Undisputed	01/23/2026	1086129298	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$24.27	03/06/2024	Food and Beverage	Undisputed	01/23/2026	1118113401	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$22.35	04/11/2024	Food and Beverage	Undisputed	01/23/2026	1118113397	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$21.31	06/27/2024	Food and Beverage	Undisputed	01/23/2026	1118113395	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$22.38	09/04/2024	Food and Beverage	Undisputed	01/23/2026	1118113399	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$17.98	10/29/2024	Food and Beverage	Undisputed	01/23/2026	1118113393	CMS
E.R. Squibb & Sons, L.L.C.	$20.71	02/08/2024	Food and Beverage	Undisputed	01/23/2026	1101392570	CMS
E.R. Squibb & Sons, L.L.C.	$19.60	06/26/2024	Food and Beverage	Undisputed	01/23/2026	1101392596	CMS
Esperion Therapeutics, Inc.	$14.84	11/13/2024	Food and Beverage	Undisputed	01/23/2026	1129431280	CMS
Exact Sciences Corporation	$29.90	11/20/2024	Food and Beverage	Undisputed	01/23/2026	1114616311	CMS
GlaxoSmithKline, LLC.	$16.54	05/17/2024	Food and Beverage	Undisputed	01/23/2026	1116124681	CMS
GlaxoSmithKline, LLC.	$15.19	06/25/2024	Food and Beverage	Undisputed	01/23/2026	1116681063	CMS
GlaxoSmithKline, LLC.	$13.92	11/14/2024	Food and Beverage	Undisputed	01/23/2026	1116650017	CMS
IDORSIA PHARMACEUTICALS US INC	$17.67	01/10/2024	Food and Beverage	Undisputed	01/23/2026	1146763007	CMS
IDORSIA PHARMACEUTICALS US INC	$17.67	04/23/2024	Food and Beverage	Undisputed	01/23/2026	1146778287	CMS
IDORSIA PHARMACEUTICALS US INC	$19.86	11/05/2024	Food and Beverage	Undisputed	01/23/2026	1146793268	CMS
Kowa Pharmaceuticals America, Inc.	$13.87	12/17/2024	Food and Beverage	Undisputed	01/23/2026	1113465053	CMS
Lilly USA, LLC	$16.06	05/14/2024	Food and Beverage	Undisputed	01/23/2026	1135997299	CMS
Lilly USA, LLC	$19.49	09/17/2024	Food and Beverage	Undisputed	01/23/2026	1136020442	CMS
Lilly USA, LLC	$17.20	11/12/2024	Food and Beverage	Undisputed	01/23/2026	1136020444	CMS
Novartis Pharmaceuticals Corporation	$19.83	11/07/2024	Food and Beverage	Undisputed	01/23/2026	1086778249	CMS
Novo Nordisk Inc	$13.21	01/12/2024	Food and Beverage	Undisputed	01/23/2026	1097059117	CMS
Novo Nordisk Inc	$15.05	01/18/2024	Food and Beverage	Undisputed	01/23/2026	1097570661	CMS
Novo Nordisk Inc	$7.25	02/28/2024	Food and Beverage	Undisputed	01/23/2026	1096575287	CMS
Novo Nordisk Inc	$22.91	03/21/2024	Food and Beverage	Undisputed	01/23/2026	1096989831	CMS
Novo Nordisk Inc	$20.88	04/10/2024	Food and Beverage	Undisputed	01/23/2026	1097583067	CMS
Novo Nordisk Inc	$22.34	04/30/2024	Food and Beverage	Undisputed	01/23/2026	1096684561	CMS
Novo Nordisk Inc	$6.50	06/18/2024	Food and Beverage	Undisputed	01/23/2026	1097269622	CMS
Novo Nordisk Inc	$22.07	07/25/2024	Food and Beverage	Undisputed	01/23/2026	1097255124	CMS
Novo Nordisk Inc	$21.04	07/30/2024	Food and Beverage	Undisputed	01/23/2026	1097457075	CMS
Novo Nordisk Inc	$22.38	08/28/2024	Food and Beverage	Undisputed	01/23/2026	1096855841	CMS
Novo Nordisk Inc	$20.63	09/18/2024	Food and Beverage	Undisputed	01/23/2026	1097733783	CMS
Novo Nordisk Inc	$25.10	10/10/2024	Food and Beverage	Undisputed	01/23/2026	1097319346	CMS
Novo Nordisk Inc	$20.49	10/22/2024	Food and Beverage	Undisputed	01/23/2026	1097172149	CMS
Novo Nordisk Inc	$17.70	12/19/2024	Food and Beverage	Undisputed	01/23/2026	1097271102	CMS
PFIZER INC.	$19.70	07/16/2024	Food and Beverage	Undisputed	01/23/2026	1131782154	CMS
PFIZER INC.	$15.27	08/13/2024	Food and Beverage	Undisputed	01/23/2026	1131845803	CMS
PFIZER INC.	$26.45	09/04/2024	Food and Beverage	Undisputed	01/23/2026	1131878634	CMS
PFIZER INC.	$26.15	10/17/2024	Food and Beverage	Undisputed	01/23/2026	1132087982	CMS
Sumitomo Pharma America, Inc.	$21.62	06/11/2024	Food and Beverage	Undisputed	01/23/2026	1148838615	CMS
Sumitomo Pharma America, Inc.	$23.25	08/01/2024	Food and Beverage	Undisputed	01/23/2026	1148838617	CMS
Sumitomo Pharma America, Inc.	$24.92	10/24/2024	Food and Beverage	Undisputed	01/23/2026	1148838619	CMS

Source & provenance

Dataset: CMS Open Payments — General Payments
Publisher of source data: Centers for Medicare & Medicaid Services
CMS publication date: 2026-01-23
Program years on this page: 2020, 2022, 2023, 2024
Source files: Dataset page · Bulk file · PY2020 , PY2022 , PY2023 , PY2024
Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.